An international consortium showed that patients with depression and increased appetite and/or weight (A/W) carried a higher number of genetic risk variants for body mass index (BMI) and levels of C-reactive protein (CRP) and leptin. Data sets were drawn from case-control, cohort, and population-based studies, with established psychiatric diagnoses and genome-wide genotype data from September 28, 2015, through May 20, 2017. There were 11 837 participants with major depressive disorder (MDD) and 14 791 control individuals, 59.1% female. Among participants with MDD, 5347 (45.2%) were classified in the decreased A/W and 1871 (15.8%) in the increased A/W subgroups. Common genetic variants explained approximately 10% of the heritability in the 2 subgroups. The increased A/W subgroup showed a strong and positive genetic correlation with BMI, whereas the decreased A/W subgroup showed an inverse correlation. Furthermore, the increased A/W subgroup had a higher polygenic risk for increased BMI (odds ratio [OR], 1.18) and levels of CRP (OR, 1.08) and leptin (OR, 1.09). The findings suggest that the established phenotypic associations between atypical depressive symptoms and obesity-related traits may arise from shared pathophysiologic mechanisms. Source: https://jamanetwork.com/
The American Cancer Society (ACS) concludes that the benefits of PSA-based screening for prostate cancer…
Proton pump inhibitor (PPI) use was modestly associated with incident dementia in older adults (pooled…
Extended follow-up of three major trials consistently shows that an initial invasive strategy does not…
Escitalopram, duloxetine, and agomelatine achieved higher sustained response rates than fluoxetine, while escitalopram and duloxetine…
Targeting a systolic blood pressure (BP) of less than 120 mm Hg lowered the incidence…
In patients with type 2 diabetes (T2D) and high cardiovascular risk, targeting a systolic blood…
This website uses cookies.